PARTICIPA

PARTICIPA

lunes, 19 de agosto de 2013

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial : The Lancet Oncology

http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(11)70286-8/fulltext#aff1


Enviado desde mi iPad

No hay comentarios:

Publicar un comentario

Danos tu opinion, enriquece el post.